Physician profile
Swati C Modi
NPI 1548263809
$2,990.24
in general payments reported to CMS, 2019-2025
10 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $130 · 2021: $269 · 2022: $183 · 2023: $183 · 2024: $1,557 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Travel and Lodging: $993 · Entertainment: $78.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.60 |
| Travel and Lodging | $993.16 |
| Entertainment | $78.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,311.34 | 2019-2025 | Tremfya, Simponi Aria |
| Janssen Research & Development, LLC | $1,191.07 | 2024 | |
| Spark Therapeutics, INC. | $130.99 | 2019 | |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
| Optos, INC. | $78.28 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $58.19 | 2020-2024 | Cequa |
| Genzyme Corporation | $48.74 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.72 | 2019 | |
| Dompe US, INC. | $16.50 | 2025 | Oxervate |
| Apellis Pharmaceuticals, INC. | $13.55 | 2024 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swati Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.